If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Boscarino is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Factor XIII Medicine & Life Sciences
von Willebrand Diseases Medicine & Life Sciences
Hemophilia A Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Half-Life Medicine & Life Sciences
Differential Diagnosis Medicine & Life Sciences
Type 1 von Willebrand Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

von Willebrand Diseases
von Willebrand Factor
Differential Diagnosis
Type 1 von Willebrand Disease

Real-life experience in switching to new extended half-life products at European haemophilia centres

Peyvandi, F., Garagiola, I., Boscarino, M., Ryan, A., Hermans, C. & Makris, M., Jan 1 2019, In : Haemophilia. 25, 6, p. 946-952

Research output: Contribution to journalArticle

Hemophilia A
Hemophilia B
Pharmaceutical Preparations
Patient Care

Minimal factor XIII activity level to prevent major spontaneous bleeds

Menegatti, M., Palla, R., Boscarino, M., Bucciarelli, P., Muszbek, L., Katona, E., Makris, M., Peyvandi, F., Halimeh, S., Lachmann, B., Bidlingmaier, C., Platokouki, H., Pergantou, H., Siboni, S. M., Schutgens, R. E. G., Borhany, M., Fatima, N., Mikovic, D., Saracevic, M., De Moerloose, P. & 11 others, Casini, A., Ozdemir, N., Ay, Y., Mumford, A., Harvey, A., Payne, J., Shapiro, A. D., Williamson, A., Chapin, J., Hsu, F. & the PRO-RBDD study group, Sep 1 2017, In : Journal of Thrombosis and Haemostasis. 15, 9, p. 1728-1736 9 p.

Research output: Contribution to journalArticle

Factor XIII
Factor XIII Deficiency
Prospective Studies